Cohiba Pharmaceuticals Pvt. Ltd. is a growing PCD Pharma Franchise Company for Capsules in India, offering a diverse range of pharmaceutical formulations across multiple therapeutic segments. The company provides capsules, softgel capsules, tablets, syrups, dry syrups, injectables, drops, gels, and suspensions, giving franchise partners access to a broad pharmaceutical product portfolio.
The company's capsule portfolio includes various formulations, such as gastrointestinal, nutritional, anti-infective, and other therapeutic products. Its listed products include formulations such as Esomquto DSR Capsule, Esomquto L Capsule, Omeleaf-D Capsule, and Calflura Plus Soft Gelatin Capsules. The company states that its pharmaceutical products are manufactured through WHO-GMP and GMP-compliant facilities and are subjected to quality testing.
Cohiba Pharmaceuticals offers monopoly-based PCD Pharma Franchise opportunities, providing franchise associates with exclusive territory rights, promotional materials, marketing support, competitive pricing, and product availability. The company also emphasizes fast order fulfillment through its distribution network and supports business partners with regular marketing updates and promotional tools.
With a diversified product portfolio, quality-focused approach, and franchise support system, Cohiba Pharmaceuticals continues to expand its presence across India. Its capsule and softgel range makes it a suitable option for entrepreneurs searching for a reliable PCD Pharma Franchise Company for Capsules.
Cohiba Pharmaceuticals follows GMP and WHO-oriented manufacturing practices with quality checks throughout production to maintain the safety, purity, consistency, and reliability of its pharmaceutical products.
To provide quality pharmaceutical formulations while empowering franchise partners through reliable products, professional marketing support, monopoly opportunities, and customer-focused business solutions.
To become a trusted pharmaceutical franchise partner by expanding its product portfolio, strengthening distribution networks, and delivering safe and reliable healthcare solutions across India.
N/A